Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 152 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1511 7.3 months Advanced urothelial cancer 4 Chemotherapy
Institute of Medical Life Science, Mie University Graduate School of Medicine Japan 8/2010
Treatment Details: Patients: This study involved 13 previously-treated advanced urothelial cancer patients with an average age of 65.2 years; 11 of the patients were male. Treatment: Patients in this stud
 
1512 7.3 months Metastatic Prostate Cancer 5 Hormone
Netherlands Cancer Institute Netherlands 4/2014
Treatment Details: Patients: This study involved 61 metastatic, castrate-resistant prostate cancer patients who previously received docetaxel and abiraterone acetate. The median patient age was 69 years. T
 
1513 7.2 months Metastatic melanoma 4 Chemotherapy
Immunotherapy
Tampere University Hospital Finland 5/2009
Treatment Details: Patients: This study involved 22 metastatic melanoma patients with a median age of 56 years; 50% were male. Treatment: Patients were treated with the chemotherapy agents carboplatin and
 
1514 7.2 months Advanced NSCLC 5 Biologic therapy
Sarah Cannon Research Institute United States 6/2011
Treatment Details: Patients: This study involved previously treated advanced non-small cell lung cancer patients who were divided into 2 treatment groups. Group A consisted of 111 patients with a median age
 
1515 7.2 months Hormone-refractory prostate cancer 4 Radiation
Academic Hospital Netherlands 11/2003
Treatment Details: Patients: This Phase III study involved a total of 203 patients. Patients were divided into two groups: Group 1 with 101 patients and Group 2 with 102 patients. Median PSA for patients in
 
1516 7.2 months Recurrent GBM 3 Biologic therapy
Royal North Shore Hospital, University of Sydney Australia 8/2001
Treatment Details: Patients: Forty-two patients with recurrent glioblastoma multiforme were enrolled in this Phase II study. Treatment: Treatment consisted of the administration of the anti-angiogenesis dr
 
1517 7.1 months metastatic colon cancer 3 Biologic therapy
Princess Margaret Hospital Canada 8/2005
Treatment Details: Patients: This Phase II study involves 19 patients with metastatic colorectal cancer (17 colon, 2 rectal). Nine patients were men, and ten were women. The median age was 62. All patients
 
1518 7.1 months rectal cancer (metastatic) 3 Biologic therapy
Princess Margaret Hospital Canada 8/2005
Treatment Details: Patients: This Phase II study involves 19 patients with metastatic colorectal cancer (17 colon, 2 rectal). Nine patients were men, and ten were women. The median age was 62. All patients
 
1519 7.1 months NSCLC 4 Chemotherapy
St. James’s University Hospital United Kingdom 4/2011
Treatment Details: Patients: This study involved patients with previously treated non-small cell lung cancer who were divided into two separate treatment groups. Group A consisted of 25 patients with a media
 
1520 7.1 months Recurrent GBM 4 Biologic therapy
Chemotherapy
Clinical Center of the National Institutes of Health United States 2/2009
Treatment Details: Patients: This phase II trial involved 48 recurrent glioblastoma patients, 28 (58%) of whom were male. The median age of the group was 53 years, with a range of 21-69. Treatment: Patie
 
Page 152 of 187  | Previous Page  | Next Page